Ćeriman Krstić, V.; Soldatović, I.; Gajić, M.; Samardžić, N.; Stević, R.; Čolić, N.; Lukić, K.; Šeha, B.; Radončić, D.; Stamenić, S.;
et al. Long-Term Outcomes in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression. Curr. Oncol. 2025, 32, 229.
https://doi.org/10.3390/curroncol32040229
AMA Style
Ćeriman Krstić V, Soldatović I, Gajić M, Samardžić N, Stević R, Čolić N, Lukić K, Šeha B, Radončić D, Stamenić S,
et al. Long-Term Outcomes in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression. Current Oncology. 2025; 32(4):229.
https://doi.org/10.3390/curroncol32040229
Chicago/Turabian Style
Ćeriman Krstić, Vesna, Ivan Soldatović, Milija Gajić, Natalija Samardžić, Ruža Stević, Nikola Čolić, Katarina Lukić, Biljana Šeha, Damir Radončić, Slavko Stamenić,
and et al. 2025. "Long-Term Outcomes in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression" Current Oncology 32, no. 4: 229.
https://doi.org/10.3390/curroncol32040229
APA Style
Ćeriman Krstić, V., Soldatović, I., Gajić, M., Samardžić, N., Stević, R., Čolić, N., Lukić, K., Šeha, B., Radončić, D., Stamenić, S., Savić, M., Milenković, V., Milošević Maračić, B., & Jovanović, D.
(2025). Long-Term Outcomes in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer with High PD-L1 Expression. Current Oncology, 32(4), 229.
https://doi.org/10.3390/curroncol32040229
